Australia Compounding Pharmacies Market Size & Outlook

The compounding pharmacies market in Australia is expected to reach a projected revenue of US$ 252.9 million by 2030. A compound annual growth rate of 6.2% is expected of Australia compounding pharmacies market from 2024 to 2030.
Revenue, 2023 (US$M)
$166.3
Forecast, 2030 (US$M)
$252.9
CAGR, 2024 - 2030
6.2%
Report Coverage
Australia

Australia compounding pharmacies market, 2018-2030 (US$M)

Australia

Australia compounding pharmacies market highlights

  • The Australia compounding pharmacies market generated a revenue of USD 166.3 million in 2023 and is expected to reach USD 252.9 million by 2030.
  • The Australia market is expected to grow at a CAGR of 6.2% from 2024 to 2030.
  • In terms of segment, pain management was the largest revenue generating therapeutic area in 2023.
  • Nutritional Supplements is the most lucrative therapeutic area segment registering the fastest growth during the forecast period.

Compounding pharmacies market data book summary

Market revenue in 2023USD 166.3 million
Market revenue in 2030USD 252.9 million
Growth rate6.2% (CAGR from 2023 to 2030)
Largest segmentPain management
Fastest growing segmentNutritional Supplements
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationHormone Replacement Therapy, Pain Management, Dermatology, Specialty Drugs, Nutritional Supplements, Other Therapeutic Areas
Key market players worldwideWalgreens Boots Alliance Inc, Fresh Tracks Therapeutics Inc, Fagron SA, Albertsons Companies Inc Class A, Aurora Cannabis Inc, Trxade Health Inc, Specialist Pharmacy, Galenic, Apollo Hospitals Enterprise, Formul8, Fusion Apothecary

Other key industry trends

  • In terms of revenue, Australia accounted for 1.3% of the global compounding pharmacies market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Asia Pacific, Japan compounding pharmacies market is projected to lead the regional market in terms of revenue in 2030.
  • Thailand is the fastest growing regional market in Asia Pacific and is projected to reach USD 95.7 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Compounding Pharmacies Market Scope

Compounding pharmacies market segmentation & scope
Hormone Replacement Therapy
Pain Management
Dermatology
Specialty Drugs
Nutritional Supplements
Other Therapeutic Areas
Pediatric
Adult
Geriatric
Pharmaceutical Ingredient Alteration (PIA)
Currently Unavailable Pharmaceutical Manufacturing (CUPM)
Pharmaceutical Dosage Alteration (PDA)
Other Compounding Types
Sterile
Non Sterile

Compounding Pharmacies Market Companies

Name Profile # Employees HQ Website

Australia compounding pharmacies market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to compounding pharmacies market will help companies and investors design strategic landscapes.


Pain management was the largest segment with a revenue share of 33.19% in 2023. Horizon Databook has segmented the Australia compounding pharmacies market based on hormone replacement therapy, pain management, dermatology, specialty drugs, nutritional supplements, other therapeutic areas covering the revenue growth of each sub-segment from 2018 to 2030.


  • Australia Compounding Pharmacies Therapeutic Area Outlook (Revenue, USD Million, 2018-2030)
    • Hormone Replacement Therapy
    • Pain Management
    • Dermatology
    • Specialty Drugs
    • Nutritional Supplements
    • Other Therapeutic Areas
  • Australia Compounding Pharmacies Age Cohort Outlook (Revenue, USD Million, 2018-2030)
    • Pediatric
    • Adult
    • Geriatric
  • Australia Compounding Pharmacies Compounding Type Outlook (Revenue, USD Million, 2018-2030)
    • Pharmaceutical Ingredient Alteration (PIA)
    • Currently Unavailable Pharmaceutical Manufacturing (CUPM)
    • Pharmaceutical Dosage Alteration (PDA)
    • Other Compounding Types
  • Australia Compounding Pharmacies Sterility Outlook (Revenue, USD Million, 2018-2030)
    • Sterile
    • Non Sterile

Reasons to subscribe to Australia compounding pharmacies market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Australia compounding pharmacies market databook

  • Our clientele includes a mix of compounding pharmacies market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the Australia compounding pharmacies market , including forecasts for subscribers. This country databook contains high-level insights into Australia compounding pharmacies market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Australia compounding pharmacies market size, by therapeutic area, 2018-2030 (US$M)

Australia Compounding Pharmacies Market Outlook Share, 2023 & 2030 (US$M)

Australia compounding pharmacies market size, by therapeutic area, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more